Table 2. Clinical features of donors and grafts quality classified by donor pathological steatosis severity.
| Variables | Absent | MiS group | MaS group | Mixed steatosis group | P valuea |
|---|---|---|---|---|---|
| Number (%) | 71 (50.7) | 31 (22.1) | 24 (17.1) | 14 (9.4) | NA |
| Donor variables | |||||
| Age (year) | 44.8±16.1 | 35.4±15.3* | 51.1±8.0 | 51.8±10.9 | <0.05 |
| Gender (M/F) | 56/15 | 24/7 | 20/4 | 11/3 | 0.78 |
| BMI (kg/m2) | 21.9±3.7 | 23.0±2.7 | 22.4±3.0 | 23.1±1.9 | 0.56 |
| Pre-donate blood test | |||||
| Potasium (mmol/L) | 4.2±0.8 | 3.8±1.3 | 3.9±0.9 | 3.7±1.1 | 0.21 |
| Sodium (mmol/L) | 144±9.1 | 139±29.4 | 147±9.0 | 145±9.1 | 0.34 |
| ALT (U/L) | 64.5±9.9 | 58.3±11.4 | 43.6±11.9 | 83.8±31.9 | 0.48 |
| FBG (mmol/L) | 9.5±8.7 | 9.7±3.6 | 9.0±3.6 | 12.1±5.6 | 0.72 |
| CR (μmol/L) | 110±26.6 | 113±17.6 | 117±32.1 | 143±31.7 | 0.95 |
| BUN (mmol/L) | 10.4±2.0 | 8.1±1.0 | 7.0±0.9 | 10.5±1.6 | 0.54 |
| Graft variables | |||||
| CIT (min) | 672±191 | 698±176 | 671±130 | 535±176 | 0.26 |
| WIT (min) | 15.2±7.9 | 15.5±9.3 | 15.6±6.3 | 17.1±10.9 | 0.96 |
Information was extracted from donors matched to enrolled recipients. Data was presented in mean ± SD for data in normal distribution and median (IQR) for data in abnormal distribution. a, one-way ANOVA test was assayed for normal distributed data; Mann-Whitney U test was assayed for abnormal distributed data; chi-square test was assayed for patient distribution. * represents the significant difference compared to other groups. M, male; F, female; BMI, body mass index; ALT, alanine aminotransferase; FBG, fasting blood glucose; CR, creatinine; BUN, blood urea nitrogen; CIT, cold ischemia time; WIT, warm ischemia time.